NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis $24.99 0.00 (0.00%) As of 11/6/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Avanos Medical Stock (NYSE:AVNS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avanos Medical alerts:Sign Up Key Stats Today's Range$24.99▼$24.9950-Day Range$24.99▼$24.9952-Week Range$9.30▼$25.49VolumeN/AAverage Volume700,357 shsMarket Capitalization$1.17 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Avanos Medical, Inc. develops and markets medical devices and related products, with a focus on digestive health and pain management. Its offerings include enteral feeding tubes and delivery systems, as well as devices used in regional anesthesia and non-opioid pain management. The company’s products are used in hospitals, other health care facilities and home-care settings. Avanos serves customers in the United States and internationally. Avanos traces its history to Halyard Health, which became an independent company after separating from Kimberly-Clark in 2014. Halyard Health adopted the Avanos Medical name in 2018.AI Generated. May Contain Errors. Read More Avanos Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks1st Percentile Overall ScoreAVNS MarketRank™: 0.035335689045 of 5 starsAvanos Medical scored higher than 1% of companies evaluated by MarketBeat, and ranked 890th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.8 / 5Analyst RatingReduce Consensus RatingAvanos Medical has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAvanos Medical has received no research coverage in the past 90 days.Read more about Avanos Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-11.32% Earnings GrowthEarnings for Avanos Medical are expected to decrease by -11.32% in the coming year, from $1.06 to $0.94 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -15.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -15.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 1.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for AVNS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for AVNS on MarketBeat in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have not sold or bought any company stock.Percentage Held by Insiders2.33% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avanos Medical's insider trading history. Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVNS Stock News HeadlinesSterlington Advises Avanos Medical Management Team on $1.27 Billion AcquisitionJuly 29, 2026 | businesswire.comAvanos Medical, Inc. Stockholders Approve Acquisition by American Industrial PartnersJuly 22, 2026 | prnewswire.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 13 at 1:00 AM | Weiss Ratings (Ad)Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending MergerJuly 2, 2026 | prnewswire.comAvanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNSJune 24, 2026 | businesswire.comA Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price SurgeJune 4, 2026 | finance.yahoo.comAvanos Medical, Inc. Announces First Quarter 2026 ResultsMay 5, 2026 | prnewswire.comSummers Value Partners Q1 2026 Partner LetterApril 28, 2026 | seekingalpha.comSee More Headlines AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? Avanos Medical's stock was trading at $11.23 on January 1st, 2026. Since then, AVNS shares have increased by 122.5% and is now trading at $24.99. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) announced its quarterly earnings results on Tuesday, May, 5th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.06. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include Kimberly-Clark (KMB), Bristol Myers Squibb (BMY), GE Aerospace (GE), JPMorgan Chase & Co. (JPM), AT&T (T), Visa (V) and Broadcom (AVGO). Company Calendar Today11/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (14m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 AVNS's financial health is in the Green zone, according to TradeSmith. AVNS has been in this zone for over 14 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Supplies Current SymbolNYSE:AVNS CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees4,040Year Founded2014Profitability EPS (Trailing Twelve Months)($1.61) Trailing P/E RatioN/A Forward P/E Ratio26.59 P/E GrowthN/ANet Income-$72.90 million Net Margins-10.39% Pretax Margin-9.54% Return on Equity5.39% Return on Assets3.97% Debt Debt-to-Equity Ratio0.11 Current Ratio2.48 Quick Ratio1.40 Sales & Book Value Annual Sales$715.90 million Price / Sales1.64 Cash Flow$3.42 per share Price / Cash Flow7.30 Book Value$16.73 per share Price / Book1.49Miscellaneous Outstanding Shares46,848,000Free Float45,756,000Market Cap$1.17 billion OptionableOptionable Beta1.57 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:AVNS) was last updated on 11/6/2026 by MarketBeat.com Staff. From Our PartnersWatch This NowJensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...StocksToTrade | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVNS Stock Alerts